| Name | Title | Contact Details |
|---|---|---|
Mark Beckmeyer |
Director - IT Security | Profile |
MedeAnalytics provides evidence-based insights to solve a real problem that plagues health care – how to use the immense amount of patient data collected along the care continuum to deliver cost – effective care and promote a healthier population. The platform delivers intelligence that helps healthcare organizations detect their greatest areas of risk and identify opportunities to improve their financial health. It empowers providers and health plans to collaborate and use data to strengthen their operations and improve the quality of care. MedeAnalytics` cloud-based tools have been used to analyze more than 21 billion patient encounters in the United States and United Kingdom, providing better care to more than 30 million patients and better business for 900 healthcare organizations.
Health Council Canada is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cornerstone Eye Associates is a Rochester, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
We connect world class science to consumer health. We use science and math to enable average consumers to understand their health risk relative to their peers (age & gender) based on their behaviors. We enable organizations to develop affinity with their members, employees, patients and customers by facilitating consumer-driven, personalized user experiences. We do the heavy lifting and provide you with the data. We facilitate a permanent relationship with consumers, providing value as an entry point to preventative self-directed healthcare.
Cellenkos is an early stage clinical biotechnology company that focuses on cord blood-derived T-regulatory cellular therapies for the treatment of autoimmune diseases and inflammatory conditions. Cellenkos is founded on the technologies arising from the laboratory investigations of Simrit Parmar, M.D. Cellenkos` lead product CK0801 delivers clinically meaningful doses of allogeneic cord blood T-regulatory cells to overcome immune dysfunction.